Research Article
Apelin and Atrial Fibrillation: The Role in the Arrhythmia Recurrence Prognosis
Table 1
Study population characteristic.
| | N (%) | Men (%) | FA duration (months); mean (±SD) | Previous DC (%) | Arterial hypertension
N (%) | Diabetes mellitus
N (%) | Coronary artery disease
N (%) | Atrial dimensions | | LA long. (cm) | LA trans. (cm) | RA long. (cm) | RA trans. (cm) | | Mean (±SD) | Median (min–max) | Mean (±SD) | Median (min–max) | Mean (±SD) | Median (min–max) | Mean (±SD) | Median (min–max) |
| | NDC | 15 (25%) | 12 (80%) | 9.93 (±7.95) | 4 (26.67%) | 10 (66.67%) | 3 (20%) | 3 (20%) | 6.3 (±0.38) | 6.4 (5.80–6.58) | 4.74 (±0.71) | 4.7 (3.80–6.60) | 5.81 (±0.45) | 5.8 (5.20–6.70) | 4.59 (±0.49) | 4.4 (3.90–5.70) | | SDC | 45 (75%) | 30 (66.67%) | 7.13 (±5.95) | 16 (35.56%) | 26 (57.78%) | 2 (4.4%) | 2 (4.4%) | 6.12 (±0.52) | 6.2 (4.80–7.0) | 4.86 (±0.54) | 4.9 (3.30–6.10) | 5.78 (±0.59) | 5.9 (4.00–6.80) | 4.52 (±0.71) | 4.6 (3.00–5.65) | | SDC-7 | 11 (18.32%) | 6 (54.55%) | 7.91 (±5.86) | 1 (9.09%) | 6 (54.55%) | 3 (27.27%) | 2 (18.18%) | 6.05 (±0.62) | 6 (4.80–7.0) | 4.64 (±0.60) | 4.8 (3.30–5.40) | 5.92 (±0.36) | 5.9 (5.40–6.50) | 4.1 (±0.67) | 4.1 (3.00–5.10) | | SDC-30 | 12 (20%) | 8 (66.67%) | 6.08 (±6.07) | 4 (33.33%) | 6 (50%) | 0 | 1 (8.33) | 6.05 (±0.40) | 6.2 (5.24–6.50) | 4.75 (±0.40) | 4.8 (3.94–5.50) | 5.63 (±0.57) | 5.7 (4.60–6.40) | 4.74 (±0.59) | 4.9 (3.50–5.50) | | SDC-90 | 22 (36.67%) | 16 (72.73%) | 7.32 (±6.12) | 11 (50%) | 14 (63.64%) | 0 | 0 | 6.19 (±0.54) | 6.35 (5.24–7.0) | 5.04 (±0.53) | 5.11 (3.94–6.10) | 5.79 (±0.68) | 5.95 (4.00–6.80) | 4.61 (±0.72) | 4.7 (3.50–5.65) |
|
|
